Ladose

Fluoxetine, the active ingredient in Ladose, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral use. It is prescribed to treat depressive and anxiety‑related disorders in adult patients. The medication works by increasing serotonin levels in the brain, which can improve mood, reduce compulsive thoughts, and alleviate panic symptoms.

GNH USA supplies Ladose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable access to quality‑assured products across global markets, adhering to stringent regulatory standards to guarantee product integrity and patient safety.

Fluoxetine is an SSRI that addresses several psychiatric conditions by modulating serotonin pathways.

- Major depressive disorder: reduces depressive symptoms and improves overall mood. - Obsessive‑compulsive disorder: lessens intrusive thoughts and compulsive behaviors. - Panic disorder: decreases frequency and intensity of panic attacks. - Bulimia nervosa: helps control binge‑eating and purging cycles. - Premenstrual dysphoric disorder: alleviates mood swings and physical discomfort associated with the menstrual cycle.

Fluoxetine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivary flow. - Sweating: increased perspiration. - Sexual dysfunction: decreased libido or delayed orgasm.

Serious or Rare Side Effects: - Suicidal thoughts: emergence of self‑harm ideation, especially in young adults. - Serotonin syndrome: agitation, hyperthermia, tremor, and autonomic instability. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Abnormal heart rhythm: QT prolongation or arrhythmias. - Hyponatremia: low blood sodium causing confusion or seizures. - Bleeding disorders: increased risk of gastrointestinal or intracranial hemorrhage.

When prescribing Fluoxetine, clinicians should consider several precautionary measures to ensure safe use.

- Assess psychiatric history: monitor for worsening depression or suicidal thoughts. - Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal risk. - Use caution in hepatic impairment: dose may require adjustment. - Consider drug interactions: review concomitant serotonergic agents. - Store at ambient temperature: keep in original container, protect from moisture and light.

Fluoxetine interacts with various medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid): - MAO inhibitors: risk of serotonin syndrome; a 14‑day washout is required. - Triptans: increased serotonergic activity may precipitate serotonin syndrome. - Linezolid: combined serotonergic effect can be dangerous. - St. John’s wort: additive serotonin increase. - Pimozide: may cause cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened bleeding risk. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect. - Antipsychotics: potential for increased side‑effects. - CYP2D6 inhibitors (e.g., quinidine): may raise fluoxetine plasma levels. - Alcohol: can exacerbate central nervous system depression.